Therapeutic angiogenesis with intramyocardial administration of basic fibroblast growth factor

Annals of Thoracic Surgery

Volumn 69, Issue 4, 2000, Pages 1155-1161

  Kawasuji, Michio ^a   Nagamine, Hiroshi ^a   Ikeda, Masahiro ^a   Sakakibara, Naoki ^a   Takemura, Hirofumi ^a   Fujii, Susumu ^a   Watanabe, Yoh ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR;

ACUTE HEART INFARCTION; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOG; DRUG SCREENING; ECHOCARDIOGRAPHY; HEART FUNCTION; HEART MUSCLE BLOOD FLOW; HEART VENTRICLE FUNCTION; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CORONARY VESSELS; DISEASE MODELS, ANIMAL; DOGS; FIBROBLAST GROWTH FACTOR 2; INJECTIONS; MICROSPHERES; MYOCARDIAL INFARCTION; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; RECOMBINANT PROTEINS; REGIONAL BLOOD FLOW; VENTRICULAR FUNCTION, LEFT;

EID: 0034110258     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(99)01557-X     Document Type: Article

References (23)

1. Levin D.C. Pathways and functional significance of the collateral circulation. Circulation. 50:1974;831-837.
2. Schaper W., Sharma H.S., Quinkler W., Markert T., Wunsch M., Schaper J. Molecular biologic concepts of coronary anastomosis. J Am Coll Cardiol. 15:1990;513-518.
3. Kumar S, West D, Shahabuddin S, Arnold F, Haboubi N, Reid H. Angiogenesis factors from human myocardial infarcts. Lancet 1983;2(8346):364-8.
4. Folkman J., Klagsbrun M. Angiogenic factors. Science. 35:1987;442-447.
5. Montesano R., Vassalli J.D., Baird A., Guillemin R., Orci L. Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci USA. 83:1986;7297-7301.
6. Kardami E., Fandrich R.R. Basic fibroblast growth factor in atria and ventricles of the vertebrate heart. J Cell Biol. 109:1989;1865-1875.
7. Yanagisawa-Miwa A., Uchida Y., Nakamura F., et al. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science. 257:1992;1401-1403.
8. Unger E.F., Banai S., Shou M., et al. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol. 266:1994;H1588-H1595.
9. Horrigan M.C.G., MacIsaac A.I., Nicolini F.A., et al. Reduction in myocardial infarct size by basic fibroblast growth factor after temporary coronary occlusion in a canine model. Circulation. 94:1996;1927-1933.
10. Jugdutt B.I., Michorowski B.L. Role of infarct expansion in rupture of the ventricular septum after acute myocardium infarction a two-dimensional echocardiographic study . Clin Cardiol. 10:1987;641-652.
11. Dewood M.A., Banoughs R., Spores J., et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 303:1980;897-902.
12. Battler A., Scheinowitz M., Hasdai D., et al. Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardium. J Am Coll Cardiol. 22:1993;2001-2006.
13. Cuevas P., Carceller F., Ortega S., Zazo M., Nicto I., Gimerez-Gallego M. Hypotensive activity of fibroblast growth factor. Science. 254:1991;1208-1210.
14. Kosty S.K., Kourembanos S., Wheeler W.L., et al. Basic fibroblast growth factor increases nitric oxide synthase production in bovine endothelial cells. Am J Physiol. 269:1995;H1583-H1589.
15. Padua R.R., Sethi R., Dhalla N.S., Kardami E. Basic fibroblast growth factor is cardioprotective in ischemia-reperfusion injury. Mol Cell Biochem. 143:1995;129-135.
16. Pfeffer M.A., Braunwald E. Ventricular remodeling after myocardial infarction experimental observation and clinical implications . Circulation. 81:1990;1161-1172.
17. Hutchins G.M., Bulkley B.H. Infarct expansion versus extension two different complications of acute myocardial infarction . Am J Cardiol. 41:1978;1127-1132.
18. Takeshita S., Zheng L.P., Brogi E., et al. Therapeutic angiogenesis a single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model . J Clin Invest. 93:1994;662-670.
19. Banai S., Jaklisch M.T., Shou M., et al. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factors in dogs. Circulation. 89:1994;2183-2189.
20. Harada K., Friedman M., Lopez J.J., et al. Vascular endothelial growth factor administration in chronic myocardial ischemia. Am J Physiol. 39:1996;H1791-H1802.
21. Mack C.A., Patel S.R., Schwarz E.A., et al. Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial reperfusion and function in the ischemic porcine heart. J Thorac Cardiovasc Surg. 115:1998;168-177.
22. Schumacher B., Pecher P., von Specht B.U., Stegmann T. Induction of neoangiogenesis in ischemic myocardium by human growth factors. First clinical results of a new treatment of coronary heart disease. Circulation. 97:1998;645-650.
23. Sellke F.W., Laham R.J., Edelman E.R., Pearlman J.D., Simons M. Therapeutic angiogenesis with basic fibroblast growth factor technique and early results . Ann Thorac Surg. 65:1998;1540-1544.